obesity drug news today glp-1 october 27 2025 New Daily Weight Loss Pill Aims to Take on Ozempic Meet the Americans who make

Theoretical interactions may occur with anticoagulants (warfarin), antiplatelet agents, immunosuppressants (tacrolimus), and certain statins

Lancet (London, England) 392(10157):15191529 Lam CSP, Ramasundarahettige C, Branch KRH, Sattar N, Rosenstock J, Pratley R, Del Prato S, Lopes RD, Niemoeller E, Khurmi NS et al (2022) Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial

The mechanism centers on beta-3 adrenergic receptors in adipose tissue

Mild side effects: Nausea, headache, and mild allergic reactions such as itching or rash